Skip to content
Parakho

NGL Fine Chem Ltd

NSE NGLFINEBSE 524774nglfinechem.com

Q1 FY27, unaudited

Revenue
₹136.71 Cr
Profit after tax
₹16.45 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations136.71+35.55%488.77
Other income7.36+12.26%14.85
Total income144.07+34.13%503.63
Employee benefit expense17.49+20.90%60.25
Finance costs0.97−19.88%4.40
Depreciation & amortisation4.43+28.43%16.30
Total expenses122.32+25.21%449.01
Profit before tax21.75+123.84%54.62
Tax expense5.29+155.67%12.99
Profit after tax16.45+115.22%41.63
Total comprehensive income16.10+117.42%41.40
Earnings per share
Earnings per share, basic₹26.63₹67.39
Earnings per share, diluted₹26.63₹67.39

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q4 FY26

NGL Fine-Chem reported Q4 FY26 revenue of Rs 149.23 crores, up 57% year on year and 17% sequentially, with EBITDA margin expanding to 14.35%. For the full year, revenue grew 36% to Rs 500.95 crores and profit after tax rose 128% to Rs 48.13 crores. Management attributed the growth to higher volumes across products and geographies, while noting that freight and raw material cost increases, along with forex mark-to-market provisions, weighed on sequential margins.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Filings

12 shown · 38 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 05 Oct 2026.